Trifluoroacetic acid → HCID 86712428, compound
Reaction equation
[C:1](O)([C:3]([F:6])([F:5])[F:4])=[O:2].[NH:8]1[CH2:12][CH2:11][N:10]=[C:9]1[C:13]1[CH:18]=[CH:17][C:16]([CH2:19][CH2:20][NH2:21])=[CH:15][CH:14]=1.[CH3:22][O:23][C:24]1[CH:29]=[C:28]([CH3:30])[C:27]([S:31]([N:34]([CH3:45])[CH:35]([C:37]2[O:41][CH:40]=[C:39]([C:42](O)=[O:43])[CH:38]=2)[CH3:36])(=[O:33])=[O:32])=[C:26]([CH3:46])[CH:25]=1.CCN=C=NCCCN(C)C.C1C=C2N=NN(O)C2=CC=1.O>CN(C=O)C>[F:4][C:3]([F:6])([F:5])[C:1]([NH2:8])=[O:2].[NH:10]1[CH2:11][CH2:12][N:8]=[C:9]1[C:13]1[CH:14]=[CH:15][C:16]([CH2:19][CH2:20][NH:21][C:42]([C:39]2[CH:38]=[C:37]([CH:35]([N:34]([S:31]([C:27]3[C:26]([CH3:46])=[CH:25][C:24]([O:23][CH3:22])=[CH:29][C:28]=3[CH3:30])(=[O:33])=[O:32])[CH3:45])[CH3:36])[O:41][CH:40]=2)=[O:43])=[CH:17][CH:18]=1Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared according to general procedure AH using the bis TFA salt of 2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethanamine, (40 mg, 0.1 mmol), TEA (0.05 mL, 0.32 mmol), DMF (1 mL), 5-(1-{[(4-methoxy-2,6-dimethylphenyl)sulfonyl](methyl)amino}ethyl)furan-3-carboxylic acid (39 mg, 0.11 mmol), EDCI (24 mg, 0.13 mmol) and HOBt monohydrate (17 mg, 0.13 mmol). The crude product was purified using MP-TsOH resin, washing with MeOH (5 mL) and eluting with 7N NH3 in MeOH (7 mL). A portion of the resulting partially purified product was purified using prep method C to afford the title compound.
Workup
- customThe title compound was prepared
- customThe crude product was purified
- washwashing with MeOH (5 mL)
- washeluting with 7N NH3 in MeOH (7 mL)
- customA portion of the resulting partially purified product was purified
Sources & evidence
- ORD record
- ord-e2bd8799acfa4afebb10c900752ce5eb
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08623859B2
Reaction notes
Loading…